Neequaye 1990.

Methods	Randomised, parallel group, single‐centre study (Ghana). Method of randomisation: "assigned by a randomised numbered list". Allocation concealment: unclear. Blinding: no. ITT: unclear. Withdrawals: stated.
Participants	Baseline characteristics: 46 participants screened and given 3 courses of C (27 children randomised (male:female: 16:11)). Median age: 9 years. Tumour staging: unclear. Diagnosis: histopathology. Entry criteria: stage III BL; adequate response to C. Exclusion criteria: not reported.
Interventions	Monthly intramuscular TF versus no treatment. Trial was stopped prematurely due to exhausted stocks of intervention agent. Study duration: maximum of one year. Follow‐up: median 3.3 years.
Outcomes	Relapse. Overall survival.
Notes	Full text publication. Study type: remittance maintenance.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	Randomised number list.
Allocation concealment (selection bias)	Unclear risk	Not described.
Blinding (performance bias and detection bias) All outcomes	Unclear risk	Not described.
Incomplete outcome data (attrition bias) All outcomes	Low risk	Late failures rates were accounted for.